Tax Season is Here! Save 15% on H&R Block Online
iconAll times are GMT -4. The time now is 03:16 AM. | Search:

» StockRants Stock Forum » Public Stock Forums » US Penny Stock Picks » Strong Buy: (BPAX) Mcap 71 M /Cash 70 M /FDA DECISION 14 FEB 2012



Reply
 
Thread Tools Search this Thread
Old 01-31-2012, 07:35 AM   Nav to Top  #1
Biohero
Senior Trader
 
Biohero's Avatar
 
Join Date: Jan 2012
Location: Frankfurt
Posts: 298
Favorites: Aapl celg onxx
Rep Power: 116
Reputation: 36
Biohero is on a distinguished road
Default (BPAX) Mcap 71 M /Cash 70 M /FDA DECISION 14 FEB 2012

This Goldmine currently trades at cash Level but this will change with the upcoming FDA Decision on 14th Feb . FDA approval will push this wayyy oversold goldmine back to $1.50++ easily ..

BPAX will get $5 Mil upon FDA approval and 10% royalties from partner TEVA Pharma .

Buy now and make a lot of money with the runup to FDA decision folks .GLTA


Biosante (BPAX)

Market cap : $71 M
Cash : $ 70 M

Price: 0.65



MONSTER PIPELINE :

Part 1
http://www.biosantepharma.com/Products.php

Part 2
http://www.biosantepharma.com/images/gvax-imm-chart.gif

BPAX has equity stake in external companies :

BPAX has 16% Stake in Ceregene
http://www.ceregene.com/pipeline.asp

BPAX has 19.9% Stake in Coldgenesys
http://coldgenesys.net/products


Institutions bought the hell out of it since the drop in December and now the Institutions holding more than 45 Mil shares thats the highest level in the of this Company
http://www.mffais.com/stock/biosante...icals-inc.html


Management bought most of their shares above $1.50 and they never sold a single share .
http://www.secform4.com/insider-trading/1023024.htm



Bio-T-Gel™

Bio-T-Gel™ is a once-daily transdermal testosterone gel in development for the treatment of male hypogonadism, or low testosterone levels. Male hypogonadism generally is characterized by impotence, a lack of sex drive, muscle weakness and osteoporosis. In 2010, the transdermal testosterone market for men in the U.S. was over $1.2 billion.

Bio-T-Gel™ is licensed to Teva Pharmaceuticals, USA. A Bio-T-Gel™ NDA is pending with the FDA having a PDUFA date of February 14, 2012. Teva is responsible for all regulatory and marketing activities.
Biohero is offline   Rate this post Yes | No Reply With Quote
Old 01-02-2020, 04:30 AM   Nav to Top  #2
PatrickATyler
Junior Trader
 
PatrickATyler's Avatar
 
Join Date: Jan 2020
Location: New York City
Posts: 6
Favorites: AAPL, GOOGL, AMZN
Rep Power: 7
Reputation: 10
PatrickATyler is on a distinguished road
Default

Thanks for sharing this information with us. I am looking for the best essay writing service. Can you please help me?
PatrickATyler is offline   Rate this post Yes | No Reply With Quote
Reply

Similar Threads
Thread Thread Starter Forum Replies Last Post
Strong Buy: (DND.T) FDA decision on 29 May /Mcap 24 M =1000% Potential ! Biohero Canadian Stock Picks 0 01-24-2012 08:02 AM
Strong Buy: Blockbuster approval in 4Q11(Mcap 10 M) Cash 27 M biotechmaster US Penny Stock Picks 4 04-26-2011 04:58 PM
Strong Buy: Blockbuster approval this Q (Mcap 14 M$) Trading below Cash !!! biotechmaster US Penny Stock Picks 0 01-10-2011 08:44 AM
Spec: FDA decision dates - Medical Devices kabilius US Stock Picks 0 08-01-2009 12:50 PM
NRIFF (August 5,2009 FDA decision Date) nahoma8 US Stock Picks 20 06-23-2009 10:57 AM


Thread Tools Search this Thread
Search this Thread:

Advanced Search

Posting Rules
You may not post new threads
You may not post replies
You may not post attachments
You may not edit your posts

BB code is On
Smilies are On
[IMG] code is On
HTML code is On